Related references
Note: Only part of the references are listed.Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study
Ming-Feng Xia et al.
CLINICAL NUTRITION (2021)
Diabetes duration and glycaemic control as predictors of cardiovascular disease and mortality
Fu-Rong Li et al.
DIABETES OBESITY & METABOLISM (2021)
Association between visceral adipose index and risk of hypertension in a middle-aged and elderly Chinese population
Yayun Fan et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)
Skeletal muscle mass in relation to 10 year cardiovascular disease incidence among middle aged and older adults: the ATTICA study
Stefanos Tyrovolas et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2020)
Cardiometabolic risk factors and Framingham Risk Score in severely obese patients: Baseline data from DieTBra trial
Annelisa S. A. C. Santos et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Accuracy augmentation of body composition measurement by bioelectrical impedance analyzer in elderly population
Wen-Hui Fang et al.
MEDICINE (2020)
The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes
Xiaoyou Su et al.
BMC ENDOCRINE DISORDERS (2019)
Skeletal muscle mass to visceral fat area ratio is an important determinant associated with type 2 diabetes and metabolic syndrome
Qian Wang et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes
Yoko Omura-Ohata et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications
Elisa Dal Canto et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
Changes in body composition and metabolic disease risk
Xavier Pi-Sunyer
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
Insulin resistance is a cardiovascular risk factor in humans
Maria M. Adeva-Andany et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease
Takashi Shida et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Association between skeletal muscle mass to visceral fat area ratio and arterial stiffness in Chinese patients with type 2 diabetes mellitus
Jing Xu et al.
BMC CARDIOVASCULAR DISORDERS (2018)
Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project
David Scott et al.
EXPERIMENTAL GERONTOLOGY (2018)
Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women
Di Zhao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review
Thomas R. Einarson et al.
VALUE IN HEALTH (2018)
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
John A. Batsis et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Muscle Mass and Body Fat in Relation to Cardiovascular Risk Estimation and Lipid-Lowering Eligibility
Kayoung Lee
JOURNAL OF CLINICAL DENSITOMETRY (2017)
The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype
You-Cheol Hwang et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population The China-PAR Project (Prediction for ASCVD Risk in China)
Xueli Yang et al.
CIRCULATION (2016)
Role of adiponectin and free fatty acids on the association between abdominal visceral fat and insulin resistance
Aida Medina-Urrutia et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Relationship between Sarcopenic Obesity and Cardiovascular Disease Risk as Estimated by the Framingham Risk Score
Jeong-Hyeon Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Exercise reduces cellular stress related to skeletal muscle insulin resistance
Mariana Aguiar de Matos et al.
CELL STRESS & CHAPERONES (2014)
Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Population-Based Cohort Study of Older Men
Janice L. Atkins et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
Insulin resistance and hyperglycaemia in cardiovascular disease development
Markku Laakso et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
A coronary heart disease prediction model: the Korean Heart Study
Sun Ha Jee et al.
BMJ OPEN (2014)
Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008-2010 Korea National Health and Nutrition Examination Survey
S. J. Baek et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
Sarcopenic obesity as an independent risk factor of hypertension
Seung Ha Park et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2013)
Sarcopenia Is Independently Associated with Cardiovascular Disease in Older Korean Adults: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2009
Sang Ouk Chin et al.
PLOS ONE (2013)
Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: A meta-analysis
Yoichi Inaba et al.
ATHEROSCLEROSIS (2012)
Role of Muscle Mass and Muscle Quality in the Association Between Diabetes and Gait Speed
Stefano Volpato et al.
DIABETES CARE (2012)
Impact of Abdominal Visceral and Subcutaneous Adipose Tissue on Cardiometabolic Risk Factors: The Jackson Heart Study
Jiankang Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Sarcopenic-obesity and cardiovascular disease risk in the elderly
W. C. Stephen et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins
Michael L. Power et al.
BRITISH JOURNAL OF NUTRITION (2008)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
